EUVIMEDEUVIMED entdecken
Crossref

Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant- p53 Colorectal Cancer Cells to γ-Irradiation

Farideh Hosseini, Mohammad Reza Sam, Nasrollah Jabbari, Hossein Mozdarani

Cancer Biotherapy and Radiopharmaceuticals · 2018-11 · 33 (9) · 387-395

DOI: 10.1089/cbr.2018.2445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, online erschienen am 02.11.2018. Verfasst von Farideh Hosseini und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Cellular and Molecular Biotechnology, Institute of Biotechnology, Urmia University , Urmia, Iran. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutant- p53 colorectal cancer (CRC) cells are often resistant to radiotherapy. Loss of suppressor activity of wt- p53 on survivin is responsible for the enhanced expression of survivin as a radioresistant factor in tumor cells. Yet, no survivin -modulating drug has been approved for clinical application in CRC. Thus, the search for safe compounds that modulate survivin expression and induce apoptosis irrespective of p53 status may potentiate the efficacy of radiotherapy in mutant- p53 CRC cells. Omega-3 docosahexaenoic acid (DHA) induces apoptosis in malignant cells without cytotoxicity in normal cells. However, little is known whether in vitro concentrations of DHA equal to the human plasma levels are able to modulate expression of survivin and sensitize mutant- p53 CRC cells to γ-irradiation. Radioresistant mutant- p53 HT-29 cells were pretreated with 50- and 100-μM DHA for 48-h before 2-, 4-, 6-, 8-, and 10-Gy of γ-irradiation. Thereafter, proliferation rates were measured after 6 d. HT-29 cells were also pretreated with 50- and 100-μM DHA for 4-h before 2- and 10-Gy of γ-irradiation after which, cell number, survivin expression, caspase-3 activation, apoptosis, and ED 50 (γ-irradiation dose causing 50% growth inhibition) were evaluated. Pretreatment of HT-29 cells with 50- and 100-μM DHA for 48-h followed by 2- to 10-Gy of γ-irradiation induced a dose-dependent additive decrease in cell proliferation rate and ED 50 values were decreased by 88%, 44%, 41%, and 27% for 500-, 1500-, 2500-, and 5000 cells per well pretreated with 100-μM DHA respectively. Pretreatment of 5 × 10 5 HT-29 cells per well with 100-μM DHA for 4-h followed by 2- or 10-Gy of irradiation resulted in 53% and 86% decreases in cell numbers, 2- and 5.1-fold activation in caspase-3 followed by 66% and 60% decreases in survivin mRNA levels respectively. DHA in combination with radiation increased total apoptotic rate 48-h post-treatment. DHA decreases survivin expression and induces caspase-3 activation irrespective of p53 status. Significant decreases in ED 50 values at concentrations of DHA equal to human plasma levels, suggesting that DHA could be used as an attractive radiosensitizer agent in CRC patients with mutant- p53 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisCaspase 3Cell ProliferationColorectal NeoplasmsDocosahexaenoic AcidsGamma RaysHT29 CellsHumansMutationRadiation ToleranceRadiation-Sensitizing AgentsSurvivinTumor Suppressor Protein p53

Stichwörter der Autor:innen

apoptosiscaspase-3colorectal cancerdocosahexaenoic acidradiosensitizerradiotherapysurvivin

Substanzen

BIRC5 protein, humanRadiation-Sensitizing AgentsSurvivinTP53 protein, humanTumor Suppressor Protein p53Docosahexaenoic AcidsCASP3 protein, humanCaspase 3

Autor:innen und Institutionen

  • 1 Department of Cellular and Molecular Biotechnology, Institute of Biotechnology, Urmia University , Urmia, Iran .
  • 2 Department of Radiology Technology, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences , Tehran, Iran .
  • 3 Department of Medical Physics and Imaging, Solid Tumor Research Center, Urmia University of Medical Sciences , Urmia, Iran .
  • 4 Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University , Tehran, Iran .

Zitieren

APA

Hosseini, F., Sam, M. R., Jabbari, N., & Mozdarani, H. (2018). Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant- p53 Colorectal Cancer Cells to γ-Irradiation. Cancer Biotherapy and Radiopharmaceuticals, 33(9), 387-395. https://doi.org/10.1089/cbr.2018.2445

Vancouver

Hosseini F, Sam MR, Jabbari N, Mozdarani H. Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant- p53 Colorectal Cancer Cells to γ-Irradiation. Cancer Biotherapy and Radiopharmaceuticals. 2018;33(9):387-395. doi:10.1089/cbr.2018.2445

BibTeX
@article{Hosseini2018,
  author = {Hosseini, Farideh and Sam, Mohammad Reza and Jabbari, Nasrollah and Mozdarani, Hossein},
  title = {Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant- p53 Colorectal Cancer Cells to γ-Irradiation},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2018},
  volume = {33},
  number = {9},
  pages = {387--395},
  doi = {10.1089/cbr.2018.2445}
}
Kostenlos starten →